- Allogene Therapeutics (NASDAQ:ALLO) is scheduled to announce Q2 earnings results on Wednesday, August 13th, after market close.
- The consensus EPS Estimate is -$0.27 (+22.9% Y/Y)
- Over the last 1 year, ALLO has beaten EPS estimates 50% of the time and has
Allogene Therapeutics Q2 2025 Earnings Preview

Related
Fathom projects agent count to surpass 300 in Elevate progra...
16 minutes ago
0
Corn futures plunge after USDA forecasts record crop
17 minutes ago
0
IZEA signals sustainable profitability and cost discipline w...
29 minutes ago
0
Mobile Infrastructure signals full year 2025 revenue to trac...
38 minutes ago
0
Fractyl Health outlines upcoming REMAIN-1 and Rejuva milesto...
41 minutes ago
0
OPEC, EIA outlooks point to higher oil production this year ...
49 minutes ago
0
NEXGEL targets $13M revenue and positive EBITDA for 2025 as ...
54 minutes ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved